Influx of Technologically Advanced Biopharmaceutical and Biomedicine Drives the Biopharmaceutical and Biomedicine Market – 2025
Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/18
Launches and approvals of novel biopharmaceutical and biomedicine products is expected to drastically drive growth of global biopharmaceutical and biomedicine market in the near future. For instance, in 2016, Sanofi S.A. received U.S. FDA approval for its Adlyxin ((lixisenatide) injection. Adlyxin is indicated to improve blood sugar levels among adults suffering from type 2 diabetes. In 2016, Johnson & Johnson received U.S. FDA approval for its Stelara (Ustekinumab), indicated for the treatment of adults suffering from moderately to severely active crohn’s disease. In 2016, CSL Behring received U.S. FDA approval for its IDELVION, Coagulation Factor IX (Recombinant), Albumin Fusion Protein. IDELVION is indicated for the treatment of Hemophilia B among children and adults. In 2017, Nanostring Technologies, Inc. launched nCounter platform advances as well as new panels expanding the company’s presence in immuno-oncology and 3D biology research. In 2015, Celltrion Healthcare Co., Ltd. launched its Remsima (infliximab), a biosimilar monoclonal antibody (mAb) in Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, Sweden, and the UK.
Furthermore, increasing collaborations and acquisitions by major key players in market is also expected to create lucrative environment for growth of market. For instance, in 2016, Biocon Ltd., wholly owned subsidiary of Biocon SA, collaborated with Laboratorios PiSA S.A. de C.V—a Mexico-based company—for the co-development and commercialization of generic recombinant human insulin (rh-insulin) in the U.S. market. In 2016, AbbVie Inc. acquired all rights from Boehringer Ingelheim (BI) for Risankizumab (BI 655066). Risankizumab is an anti-IL-23 monoclonal biologic antibody for psoriasis. Company is also evaluating the product for other indications such as Crohn’s disease, asthma, and psoriatic arthritis. Currently, it is in clinical phase 3.
Increasing strategic acquisitions and collaboration by key players is expected to drive market growth in the near future
Players in the market are focusing on strategic collaborations, in order to increase their product offerings. In February 2018, LGC Limited— U.K.-based Company acquired Lucigen Corporation, a U.S.-based developer, and manufacturer of molecular biology enzymes, reagents and kits. Through this strategic acquisition, LGC Limited expanded its portfolio with the Lucigen’s extensive portfolio of NGS kits, enzymes, competent cells, and cloning systems. In February 2018, Servier Laboratories and ImmunoQure AG entered into a strategic collaboration for development of a therapeutic autoantibody neutralizing interferon- a. In March 2018, Wuxi Biologics Co. Ltd. collaborated with Adagene Inc., for the discovery and development of novel antibody therapeutics. In 2017, Omicia, Inc., acquired a bioinformatics startup Spiral Genetics at an undisclosed amount. Through this acquisition of Spiral’s advanced tools, Omicia, Inc., expanded its bioinformatics tools portfolio and strengthened its position in the global market.
Key players operating in the global biopharmaceutical and biomedicine market include;
• Amgen Inc.
• F. Hoffmann-La Roche AG
• Novartis AG
• Johnson & Johnson
• Pfizer, Inc.
• Sanofi S.A.
• Eli Lilly and Company
• AbbVie Inc.
• Novo Nordisk A/S
• Bristol - Myers Squibb
• NanoString Technologies, Inc.
• Qiagen N.V.
• Celgene Corporation
• Affimed N.V.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/18
Global Biopharmaceutical and Biomedicine Market, By Product Type :
• Monoclonal Antibodies Market
• Recombinant Human Insulin
• Human Growth Hormone
• Colony Stimulating Factor
• Blood Factors
• Fusion Protein
Cell & Gene Therapy
Molecular Enzymes & Kits Market
Global Biopharmaceutical and Biomedicine Market, By Application:
• Research and Development
Global Biopharmaceutical and Biomedicine Market, By Geography:
• North America
• Asia Pacific
• Latin America
• Middle East
Ask For Discount Before Purchase This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/18
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influx of Technologically Advanced Biopharmaceutical and Biomedicine Drives the Biopharmaceutical and Biomedicine Market – 2025 here
News-ID: 1449867 • Views: 313
More Releases from Coherent Market Insights - Biotechnology
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy
Diabetes Vaccine Market Scrutinized in New Research 2018-2026
Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses. Diabetes vaccine is being developed to strengthen the body’s response against enterovirus
More Releases for Biopharmaceutical
Biopharmaceutical Market - Massive Growth opportunity Ahead
A new research document with title 'State of the Biopharmaceutical Industry 2021' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors. The report will help user gain market insights, future trends and growth prospects for forecast period of 2021 Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/3060794-state-of-the-biopharmaceutical-industry Summary 2021 promises to be a year of continued innovation and change in the
Biopharmaceutical Logistics Market Is Thriving Worldwide |
The Biopharmaceutical Logistics Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Biopharmaceutical Logistics market report provides authentic and reliable estimates for the forecast period. It became essential to distinguish the saturation of consumption in the Biopharmaceutical Logistics market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation
Biopharmaceutical Drug Delivery Technologies Market Size, Share, Development by …
New report published by Global Info Research which offers insights on the Global Biopharmaceutical Drug Delivery Technologies market. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-biopharmaceutical-drug-delivery-technologies-market_p103529.html Global Biopharmaceutical Drug Delivery Technologies Market: Forecast by Type / Application / Region This report studies the Biopharmaceutical Drug Delivery Technologies market status and
Biopharmaceutical Contract Manufacturing (BCMO) Market 2018 – 2024 | PBIGP
A Study On Biopharmaceutical Contract Manufacturing (BCMO) Market: Biopharmaceutical products are pharmaceutical drugs that are synthesized, processed, or extracted from biological sources. Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues and living cells used in cell therapy. Due to lack of manufacturing capabilities and to reduce the cost of manufacturing process, many companies are outsourcing. Contract manufacturing organizations offer a wide range of services such as
Biopharmaceutical and Biomedicine Market Insights, and Forecast to 2025
Biopharmaceuticals has emerged as one of the key segments with immense growth potential in the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players in the recent past. The industry offers lucrative growth opportunities, since most of these products still have low penetration rate. The market is expected to gain further traction, with evolving treatment
Global Biopharmaceutical Contract Manufacturing Market 2025
Press Release - 16 July 2018 Research and Development News -- . . Latest Update "Global Biopharmaceutical Contract Manufacturing Market Size,Status and Forecast 2025" with Industries Survey | Global Current Growth and Future. ' ' This report studies the global Biopharmaceutical Contract Manufacturing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Biopharmaceutical Contract Manufacturing market by companies, region, type and end-use industry. A contract manufacturer ("CM")